252 related articles for article (PubMed ID: 34797638)
1. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
2. A PDA-DTC/Cu-MnO
Hu X; Lu Y; Zhao W; Sun M; Li R; Feng L; Yao T; Dong C; Shi S
Chem Commun (Camb); 2021 Apr; 57(34):4158-4161. PubMed ID: 33908477
[TBL] [Abstract][Full Text] [Related]
3. ZD2-Engineered Gold Nanostar@Metal-Organic Framework Nanoprobes for T
Zhang L; Liu C; Gao Y; Li Z; Xing J; Ren W; Zhang L; Li A; Lu G; Wu A; Zeng L
Adv Healthc Mater; 2018 Dec; 7(24):e1801144. PubMed ID: 30370656
[TBL] [Abstract][Full Text] [Related]
4. Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.
Ming L; Song L; Xu J; Wang R; Shi J; Chen M; Zhang Y
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35444-35455. PubMed ID: 34292714
[TBL] [Abstract][Full Text] [Related]
5. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation.
Gao P; Shi M; Wei R; Pan W; Liu X; Li N; Tang B
Chem Commun (Camb); 2020 Jan; 56(6):924-927. PubMed ID: 31850458
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
Valcourt DM; Dang MN; Scully MA; Day ES
ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
[TBL] [Abstract][Full Text] [Related]
7. MnO
Wang X; Dai J; Wang X; Hu Q; Huang K; Zhao Z; Lou X; Xia F
Talanta; 2019 Sep; 202():591-599. PubMed ID: 31171226
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable Hollow Polydopamine@manganese Dioxide as an Oxygen Self-Supplied Nanoplatform for Boosting Chemo-photodynamic Cancer Therapy.
Wang H; Wang W; Liu L; Wang M; Li G; Li H; Li B; Yu S; Ma D; Xue W
ACS Appl Mater Interfaces; 2021 Dec; 13(48):57009-57022. PubMed ID: 34806877
[TBL] [Abstract][Full Text] [Related]
9. Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy.
Yin SY; Liu W; Yang J; Li J
J Mater Chem B; 2021 Jul; 9(29):5877-5886. PubMed ID: 34259273
[TBL] [Abstract][Full Text] [Related]
10. Facile Synthesis of a Cubic Porphyrin-Based Covalent Organic Framework for Combined Breast Cancer Therapy.
Liu S; Liu Z; Meng Q; Chen C; Pang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56873-56880. PubMed ID: 34797623
[TBL] [Abstract][Full Text] [Related]
11. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
12. Bimetallic metal-organic frameworks for tumor inhibition
Li A; Wang N; Song Y; Sun H; Cui J; Zhang G; Yu Q
Chem Commun (Camb); 2022 Feb; 58(14):2315-2318. PubMed ID: 35076033
[TBL] [Abstract][Full Text] [Related]
13. Grafting of Gd-DTPA onto MOF-808 to enhance MRI performance for guiding photothermal therapy.
Jia M; Yang X; Chen Y; He M; Zhou W; Lin J; An L; Yang S
J Mater Chem B; 2021 Oct; 9(41):8631-8638. PubMed ID: 34585715
[TBL] [Abstract][Full Text] [Related]
14. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer.
Sun Q; Hou X; Yang J; Zhang M; Yang Y; Liu Y; Shen W; Yin D
ACS Appl Mater Interfaces; 2021 Nov; 13(46):55577-55590. PubMed ID: 34762394
[TBL] [Abstract][Full Text] [Related]
15. Boosting Chemodynamic Therapy
Yao J; Yang F; Zheng F; Yao C; Xing J; Xu X; Wu A
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54770-54782. PubMed ID: 34780685
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
17. Missing-Linker-Assisted Artesunate Delivery by Metal-Organic Frameworks for Synergistic Cancer Treatment.
Wang D; He IW; Liu J; Jana D; Wu Y; Zhang X; Qian C; Guo Y; Chen X; Bindra AK; Zhao Y
Angew Chem Int Ed Engl; 2021 Dec; 60(50):26254-26259. PubMed ID: 34591365
[TBL] [Abstract][Full Text] [Related]
18. Near-Infrared Emissive Lanthanide Metal-Organic Frameworks for Targeted Biological Imaging and pH-Controlled Chemotherapy.
Cui R; Sun W; Liu M; Shi J; Liu Z
ACS Appl Mater Interfaces; 2021 Dec; 13(49):59164-59173. PubMed ID: 34851097
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
20. Trojan-Horse Diameter-Reducible Nanotheranostics for Macroscopic/Microscopic Imaging-Monitored Chemo-Antiangiogenic Therapy.
Fan Z; Shi D; Zuo W; Feng J; Ge D; Su G; Yang L; Hou Z
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5033-5052. PubMed ID: 35045703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
